ES2065846B1 - PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. - Google Patents
PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.Info
- Publication number
- ES2065846B1 ES2065846B1 ES9300826A ES9300826A ES2065846B1 ES 2065846 B1 ES2065846 B1 ES 2065846B1 ES 9300826 A ES9300826 A ES 9300826A ES 9300826 A ES9300826 A ES 9300826A ES 2065846 B1 ES2065846 B1 ES 2065846B1
- Authority
- ES
- Spain
- Prior art keywords
- agents
- steroid
- present
- pharmaceutical formulation
- inflammatory agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FORMULACION FARMACEUTICA A BASE DE UN AGENTE ANTIINFLAMATORIO ESTEROIDICO O NO ESTEROIDICO Y UN ANTIBIOTICO PERTENECIENTE AL GRUPO DE LOS INHIBIDORES DE LA ADN GIRASA PARA SU UTILIZACION TOPICA OFTALMICA COMPRENDE: 0,001-5,0% DE UN AGENTE ANTIINFLAMATORIO ESTEROIDICO O NO ESTEROIDICO O UN ISOMERO, O UN ESTER, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES; 0,05-5,0% DE UN INHIBIDOR DE LA ADN GIRASA, O UN ISOMERO, O UN ESTER O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES; Y OPCIONALMENTE, UNO O MAS INGREDIENTES SELECCIONADOS ENTRE AGENTES ISOTONIZANTES, AMORTIGUADORES DEL PH, AGENTES VISCOSIZANTES, AGENTES HUMECTANTES, AGENTES QUELANTES, AGENTES ANTIOXIDANTES Y/O AGENTES CONSERVADORES, ADEMAS DE UNO O VARIOS EXCIPIENTES ADECUADOS A LA FORMA DE PRESENTACION FARMACEUTICA DE LA FORMULACION. DICHA FORMULACION PRESENTA UN PH COMPRENDIDO ENTRE 4 Y 9. APLICACION EN EL TRATAMIENTO DE PROCESOS INFLAMATORIOS OCULARES ACOMPAÑADOS DE INFECCION.PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GROUP OF GYRASE DNA INHIBITORS, INCLUDES: A NON-STERILE NON-STERILE ANTI-PHYSICAL AGENT OR AN ESTER, OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS; 0.05-5.0% OF A GYRASE DNA INHIBITOR, OR AN ISOMER, OR AN ESTER OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS; AND OPTIONALLY, ONE OR MORE SELECTED INGREDIENTS AMONG ISOTONIZING AGENTS, SHOCK ABSORBERS, VISCOSIZING AGENTS, WETTING AGENTS, CHEATING AGENTS, ANTIOXIDANT AGENTS AND / OR PRESENT AGENTS, SEARCHERS OF EXPANDING LAWYERS, ADEMENTS, PRESENT TOWARDS, EXPANDING DEMANDERS, PRESENT AGENTS, AND SEEKERS WHO ARE PRESENT TOWARD DEMONSTRAINERS, PRESENT AGENTS, AND SEEKERS WHO ARE PRESENT TOWARD ANYOXIDANTS AND PRESENT AGENTS. THE FORMULATION PRESENTS A PH INCLUDED BETWEEN 4 AND 9. APPLICATION IN THE TREATMENT OF EYE INFLAMMATORY PROCESSES ACCOMPANIED BY INFECTION.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9300826A ES2065846B1 (en) | 1993-04-20 | 1993-04-20 | PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9300826A ES2065846B1 (en) | 1993-04-20 | 1993-04-20 | PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2065846A1 ES2065846A1 (en) | 1995-02-16 |
ES2065846B1 true ES2065846B1 (en) | 1995-10-01 |
Family
ID=8281527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9300826A Expired - Fee Related ES2065846B1 (en) | 1993-04-20 | 1993-04-20 | PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2065846B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8222407B2 (en) | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2105971B1 (en) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. |
US6274592B1 (en) * | 1997-02-04 | 2001-08-14 | Senju Pharmaceutical Co., Ltd. | Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid |
DE19729879C2 (en) * | 1997-07-11 | 1999-07-08 | Mann Gerhard Chem Pharm Fab | Storage stable ophthalmic compositions comprising diclofenac and ofloxacin |
US6552020B1 (en) | 1999-07-30 | 2003-04-22 | Allergan, Inc. | Compositions including antibiotics and methods for using same |
CN1158994C (en) * | 1999-09-24 | 2004-07-28 | 爱尔康公司 | Topcial suspension formulations containing ciprofloxacin and dexa methasone |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
US20030139382A1 (en) | 2001-09-21 | 2003-07-24 | Alcon, Inc. | Method of treating middle ear infections |
DE10161077A1 (en) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Highly concentrated stable meloxicam solutions for needleless injection |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US7514451B2 (en) | 2003-09-10 | 2009-04-07 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
CN102647971B (en) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | For comprising the container of the compositions of meloxicam |
BR112012022073A2 (en) | 2010-03-03 | 2017-10-31 | Boehringer Ingelheim Vetmedica Gmbh | use of meloxicam for the long-term treatment of musculoskeletal disorders in cats. |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
EP2502616A1 (en) * | 2011-03-21 | 2012-09-26 | Matthew Krayenbuhl | Pharmaceutical nasal composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3704907A1 (en) * | 1987-02-17 | 1988-08-25 | Bayer Ag | TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS |
AU4201189A (en) * | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
IL98179A0 (en) * | 1990-05-21 | 1992-06-21 | Norwich Eaton Pharma | Pharmaceutical compositions containing phenylpropanolamine |
-
1993
- 1993-04-20 ES ES9300826A patent/ES2065846B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8222407B2 (en) | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
Also Published As
Publication number | Publication date |
---|---|
ES2065846A1 (en) | 1995-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2065846B1 (en) | PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. | |
ECSP941104A (en) | DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AR050838A1 (en) | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OPTICAL INFECTION | |
ES2186015T3 (en) | DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL. | |
AR044923A1 (en) | IMIDAZOQUINOLINAS REPLACED WITH SULFONAMIDE | |
PA8499101A1 (en) | COMPOSITION OF CLINDAMYCIN INTRAVAGINAL OVULES | |
ES2068862T3 (en) | DERIVATIVE OF 3'-HYDROXIBENZOXAZINORIFAMICINA; PROCEDURE FOR THE PREPARATION OF THE SAME AND ANTIBACTERIAL AGENT THAT CONTAINS THE SAME. | |
ES2079589T3 (en) | PHARMACEUTICAL AGENTS. | |
PA8451801A1 (en) | DERIVATIVES OF 9-OXYME ERYTHROMYCIN | |
PA8485601A1 (en) | AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS. | |
MX9400037A (en) | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND EYE HYPERTENSION. | |
CO5261519A1 (en) | NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | |
AR024998A1 (en) | NEW RETINOIDS FOR THE TREATMENT OF THE DISEASE | |
ES2183817T3 (en) | METAZOAR PARASATIS PROTEASES INIBIDORS. | |
AR007021A1 (en) | DERIVATIVES OF 3-DESCLADINOSA-2,3-ANHIDROERITROMICINA, PROCEDURES FOR ITS PREPARATION, COMPOUNDS FOR ITS EXCLUSIVE USE IN SUCH PROCEDURES AND PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION TO TREAT BACTERIAL INFECTIONS AND THE USE OF THESE COMPUTERS | |
MX9300399A (en) | HETEROTRICICLIC DERIVATIVES. | |
MX9205123A (en) | DERIVATIVES OF 5-HYDROXY-2-PIRIMIDINYL METHYLENE USEFUL AS ANTI-INFLAMMATORY AGENTS. | |
ES2078175B1 (en) | PHARMACEUTICAL FORMULATION CONTAINING CLOBETASONE AND TOBRAMYCIN AND ITS APPLICATIONS. | |
ECSP055625A (en) | BETA-LACTAMASA INHIBITOR PROFARMACO | |
AR006345A1 (en) | A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INCLUDING AN HIV PROTEASE INHIBITOR AND A WATER-SOLUBLE TOCOFEROL DERIVATIVE, AND A METHOD FOR PREPARING SUCH COMPOSITION. | |
AR025351A1 (en) | PAR SELECTIVE RETINOID AGONISTS | |
ES2171743T3 (en) | DERIVATIVES OF AMIDINES AND ISOTIOURES AS INHIBITORS OF THE SYNTHETIC ENZYME OF NITRIC OXIDE. | |
ES2123821T3 (en) | SPRAY FORMULATION THAT HAS A REFRESHING EFFECT. | |
CO5261624A1 (en) | NEW FENILHETEROALQUILAMINE DERIVATIVES, PROCESSES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH NEW NOVEDOUS DERIVATIVES AND THEIR USE IN THERAPY | |
AR041999A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AMBROXOL AND ISOPROPAMIDE IODURE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20101018 |